1,105
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

Effectiveness of vaccination with the pentavalent rotavirus vaccine in Nicaragua as determined using the screening method

, , &
Pages 1449-1453 | Received 20 Dec 2012, Accepted 17 Mar 2013, Published online: 09 Apr 2013

References

  • Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, WHO-coordinated Global Rotavirus Surveillance Network. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:136 - 41; http://dx.doi.org/10.1016/S1473-3099(11)70253-5; PMID: 22030330
  • World Health Organization. List of member states by WHO region and mortality stratum. The World Health Report 2003—shaping the future. WHO 2004. Available at: http://www.who.int/whr/2003/en/member_states_182-184_en.pdf. Accessed November 26, 2012.
  • Amador JJ, Vasquez J, Orozco M, Pedreira C, Malespin O, De Oliveira LH, et al. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program. Int J Infect Dis 2010; 14:e592 - 5; http://dx.doi.org/10.1016/j.ijid.2009.08.014; PMID: 20022778
  • World Bank. Nicaragua: supporting progress in Latin America’s second-poorest country. 2009. Available at: http://siteresources.worldbank.org/IDA/Resources/IDA-Nicaragua.pdf. Accessed November 26, 2012.
  • UNICEF. At a glance: Nicaragua. 2010. Available at: www.unicef.org/infobycountry/nicaragua_statistics.html. Accessed November 26, 2012.
  • Bégué RE, Perrin K. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice. Pediatrics 2010; 126:e40 - 5; http://dx.doi.org/10.1542/peds.2009-2069; PMID: 20587671
  • Staat MA, Payne DC, Donauer S, Weinberg GA, Edwards KM, Szilagyi PG, et al, New Vaccine Surveillance Network (NVSN). Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics 2011; 128:e267 - 75; http://dx.doi.org/10.1542/peds.2010-3722; PMID: 21768317
  • Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010; 125:e199 - 207; http://dx.doi.org/10.1542/peds.2009-1021; PMID: 20083525
  • Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics 2010; 125:e208 - 13; http://dx.doi.org/10.1542/peds.2009-1246; PMID: 20100757
  • Tate JE, Mutuc JD, Panozzo CA, Payne DC, Cortese MM, Cortes JE, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 2011; 30:Suppl S30 - 4; http://dx.doi.org/10.1097/INF.0b013e3181ffe3eb; PMID: 21183838
  • Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:606 - 14; http://dx.doi.org/10.1016/S0140-6736(10)60889-6; PMID: 20692030
  • Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:615 - 23; http://dx.doi.org/10.1016/S0140-6736(10)60755-6; PMID: 20692031
  • Patel M, Pedreira C, De Oliveira LH, Tate J, Orozco M, Mercado J, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009; 301:2243 - 51; http://dx.doi.org/10.1001/jama.2009.756; PMID: 19491186
  • Khawaja S, Cardellino A, Klotz D, Kuter BJ, Feinberg MB, Colatrella BD, et al. Evaluating the health impact of a public-private partnership: to reduce rotavirus disease in Nicaragua. Hum Vaccin Immunother 2012; 8:777 - 82; http://dx.doi.org/10.4161/hv.19757; PMID: 22495114
  • Mast TC, Khawaja S, Espinoza F, Paniagua M, Del Carmen LP, Cardellino A, et al. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua. Pediatr Infect Dis J 2011; 30:e209 - 15; http://dx.doi.org/10.1097/INF.0b013e31822a8527; PMID: 21768920
  • Field EJ, Vally H, Grimwood K, Lambert SB. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics 2010; 126:e506 - 12; http://dx.doi.org/10.1542/peds.2010-0443; PMID: 20732946
  • Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993; 22:742 - 6; http://dx.doi.org/10.1093/ije/22.4.742; PMID: 8225751
  • Bose A, Coen P, Tully J, Viner R, Booy R. Effectiveness of meningococcal C conjugate vaccine in teenagers in England. Lancet 2003; 361:675 - 6; http://dx.doi.org/10.1016/S0140-6736(03)12563-9; PMID: 12606181
  • Savulescu C, Valenciano M, de Mateo S, Larrauri A, cycEVA Study Team. Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network—pilot case-control studies using different control groups, 2008-2009 season, Spain. Vaccine 2010; 28:2903 - 7; http://dx.doi.org/10.1016/j.vaccine.2010.01.054; PMID: 20153351
  • Andrews RM, Counahan ML, Hogg GG, McIntyre PB. Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia. Vaccine 2004; 23:132 - 8; http://dx.doi.org/10.1016/j.vaccine.2004.06.016; PMID: 15531029
  • Centers for Disease Control and Prevention. Pertussis—United States, 1997–2000. Morb Mortal Wkly Rep 2002; 51:73 - 6
  • MEASURE DHS. Demographic and Health Surveys. 2001. Available at: http://measuredhs.com/Where-We-Work/Country-Main.cfm?ctry_id=54&c=Nicaragua&Country=Nicaragua&cn=&r=6. Accessed November 6, 2012.
  • Murray CJL, Shengelia B, Gupta N, Moussavi S, Tandon A, Thieren M. Validity of reported vaccination coverage in 45 countries. Lancet 2003; 362:1022 - 7; http://dx.doi.org/10.1016/S0140-6736(03)14411-X; PMID: 14522532
  • Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985; 63:1055 - 68; PMID: 3879673
  • Chen RT, Orenstein WA. Epidemiologic methods in immunization programs. Epidemiol Rev 1996; 18:99 - 117; http://dx.doi.org/10.1093/oxfordjournals.epirev.a017931; PMID: 9021306
  • Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990; 22:259 - 67; http://dx.doi.org/10.3109/00365549009027046; PMID: 2371542
  • DiStefano DJ, Kraiouchkine N, Mallette L, Maliga M, Kulnis G, Keller PM, et al. Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis. J Clin Microbiol 2005; 43:5876 - 80; http://dx.doi.org/10.1128/JCM.43.12.5876-5880.2005; PMID: 16333070
  • Orozco M, Vasquez J, Pedreira C, De Oliveira LH, Amador JJ, Malespin O, et al. Uptake of rotavirus vaccine and national trends of acute gastroenteritis among children in Nicaragua. J Infect Dis 2009; 200:Suppl 1 S125 - 30; http://dx.doi.org/10.1086/605053; PMID: 19821709